NeuroHealing Pharmaceuticals Appoints Josh Hamermesh to Board of Directors
For Immediate Release NEWTON, Mass./EWORLDWIRE/June 30, 2014. NeuroHealing Pharmaceuticals Inc., a private clinical stage company developing drug treatments for individuals with neuro-rehabilitation needs, today announced the addition of Josh Hamermesh to the company’s Board of Directors. Josh Hamermesh has over 15 years of operating, start up, and consulting experience in the life sciences industry. He…